Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Binh Dinh Pharmaceutical And Medical Equipment JSC has a Cash Ratio of 1.11. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
STC:DBD's Cash Ratio is ranked better than 64.58% of 974
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs STC:DBD: 1.11
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Ratio Related Terms
Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Ratio Chart
Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Ratio vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a Cash Ratio of 1.11 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. This is 52% above median its historical median of 0.73. Over the past decade, Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Ratio has ranged from 0.23 to 1.15. According to the industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #345 out of 974 companies in the Drug Manufacturers industry, placing it in the top 35.4%.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Ratio too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Ratio of 1.11 is 52% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 1.15. The Drug Manufacturers industry median Cash Ratio is 0.61. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 1.11 is 82% above this industry median. Based on the distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #345 out of 974 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Binh Dinh Pharmaceutical And Medical Equipment JSC ranks #345 out of 974 companies for Cash Ratio. This puts Binh Dinh Pharmaceutical And Medical Equipment JSC in the upper half of its industry. The industry median Cash Ratio is 0.61. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 1.11 is 82% above this benchmark. Historically, Binh Dinh Pharmaceutical And Medical Equipment JSC's own Cash Ratio has ranged from 0.23 to 1.15 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 0.61, Binh Dinh Pharmaceutical And Medical Equipment JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 974 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Ratio of 1.11 is 82% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Ratio is 1.11, which is 52% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,514.28, compared to a current price of ₫49,900.00 — trading 5% below its estimated fair value. The current Cash Ratio is 1.11, which is 52% above median its 10-year median of 0.73 and 82% above the Drug Manufacturers industry median of 0.61. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current Cash Ratio is 1.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued.
The current stock price of ₫49,900.00 is trading 5% below its estimated GF Value™ of ₫52,514.28.
GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.
Key valuation signals for STC:DBD:
Cash Ratio: 1.11 (52% above median its 10-year median of 0.73)
GF Value™: ₫52,514.28 vs. price of ₫49,900.00 (5% below fair value)
Industry Position: 82% above the Drug Manufacturers median (#345 of 974)
No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score
Get the complete analysis for STC:DBD
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DBD has been successfully added to your 
